Abstract
Twenty-one previously untreated patients with extensive small cell lung cancer were treated with etoposide, 400 mg/m2/day for 3 consecutive days. Myelosuppression was severe, with a treatment-related death rate of 28%. Five partial responses were achieved. High-dose etoposide as given in this study produced unacceptable toxicity and no complete responses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 533-534 |
| Number of pages | 2 |
| Journal | Cancer Treatment Reports |
| Volume | 71 |
| Issue number | 5 |
| State | Published - 1987 |
Fingerprint Dive into the research topics of 'High-dose etoposide therapy for extensive small cell lung cancer: A cancer and leukemia group B study'. Together they form a unique fingerprint.
Cite this
Luikart, S. D., Propert, K. J., Modeas, C. R., Green, M. R., & Perry, M. C. (1987). High-dose etoposide therapy for extensive small cell lung cancer: A cancer and leukemia group B study. Cancer Treatment Reports, 71(5), 533-534.